E-701

Packaging Components Sampling Procedure

Section E — Materials Management Revision 2 6 pages

Original Document

Scanned document (image-only PDF)

Extracted Text

Searchable text extracted from PDF

1.0 Purpose 
 
 The purpose of this procedure is to define the procedure for sampling and inspection of all
 packaging components which come in contact with finished product. 
 
 2.0 Scope 
 
 This procedure is applicable for sampling and inspection of all finished product packaging
 
 components at Ion Labs including but not limited to bottles, caps, scoops, desiccants and space
 
 filler. 
 
 3.0 Responsibility 
 
 Sud It is the responsibility of Quality Control Management or designee to implement and
 
 maintain this procedure, and to review and approve written specifications for packaging
 material. 
 
 3.2. It is the responsibility of the warehouse Sampler and QC personnel to strictly follow the
 procedure. 
 
 3.3 It is the responsibility of Quality Control to maintain and engineering to distribute all
 current written specifications and supporting documentation for packaging components.
 
 3.4 Quality Control is responsible for reviewing and approving all packaging component
 specifications. 
 
 3.5 It is the responsibility of the Warehouse Sampler to ensure the correct
 Specification/Form is used while performing the inspection and it is the responsibility
 
 of the QC personnel that current specifications are retained for use.
 
 
 

[SOP 

 Standard Operating Procedure SOP No Rev No Page 
 
 Packaging Component Sampling Procedure E-701 2 of5 
 
 4.0 Definitions 
 
 4.1 Packaging Component — Any component intended for packaging related activity in the
 
 manufacture of a dietary supplement, pet product, or cosmetic. 
 
 4.2 R# - Receiving number; a unique number assigned to a component upon receipt
 
 4.3 QC — Quality Control 
 
 4.4 IPA — 70% Isopropyl Alcohol 
 
 4.5 COC -— Certificate of Compliance 
 
 5.0 References 
 
 5.1 Packaging Component Specification 
 
 Ded E-701-F1, Form, Packaging Component Inspections 
 
 Sid E-703-F1, Form, Sampling Log 
 
 5.4 C-201, SOP, Deviation and Investigation Procedure 
 
 5.5 21 CFR Part 111, Guidance, Current Good Manufacturing Practice in Manufacturing,
 
 Packaging, Labeling, or Holding Operations for Dietary Supplements
 
 6.0 Procedure 
 
 6.1 All sampling is to be performed in designated sampling rooms or booths.
 
 6.2 Prior to bringing any material into the sampling room: 
 
 6.2.1 Ensure the room and any equipment in that room is clean and free of any debris
 
 
 

[SOP 

 Standard Operating Procedure SOP No | RevNo| Page 
 
 Packaging Component Sampling Procedure E-701 8 3 of 5 
 
 and all previously inspected material is removed. 
 
 6.2.2 Spray the surfaces with IPA, wipe clean, and ensure surfaces are dry.
 
 6.2.3. Ensure gloves, lab coat/frock, hair net, safety glasses, beard cover (as
 
 applicable), and face mask are worn to prevent contamination of self and/or
 
 material when sampling. 
 
 6.3 Only one R# is to be sampled in the room/booth at any time. 
 
 6.4 Visually inspect that packaging containers are intact and packaging components being
 sampled appear free from contaminants. 
 
 6.5 Utilize Form E-701-Fl Packaging Component Inspection Form when sampling a
 packaging component. 
 
 6.6 Compare the supplier COC, Certificate of Quality, or equivalent against the container
 label (e.g. product description, lot number, part number) and ensure that they match.
 
 6.7 . Collect 5 representative samples from 5 individual containers. If less than 5 containers
 of a lot are received, collect 5 samples at random from <5 cases received.
 
 6.8 Inspect packaging components visually for contamination. 
 
 6.9 The containers shall be opened, sampled, and resealed in a manner designed to prevent
 
 contamination of their contents. 
 
 6.10 Each container from which a sample was taken should be marked, indicating that the
 container was sampled. 
 
 6.11 Retain 3 samples from the representative samples in a sealed container marked with the
 item and R# and date sampled. The retains are maintained for at least one year following
 
 the sampling date. 
 
 6.12 All sampling and inspection activities will be fully documented on Form E-701-F1
 
 Packaging Component Inspection Form, recording required information as applicable, but
 
 
 

[SOP 

 Standard Operating Procedure SOP No Rev No Page 
 
 Packaging Component Sampling Procedure E-701 4 of 5 
 
 not limited to: 
 
 * Component name 
 
 * Manufacturer/vendor 
 
 * Date received 
 
 a Manufacturer/vendor’s lot# 
 
 x Color, size, material type 
 
 6.12.1 Specifications are received from the vendor/manufacturer and are uploaded into
 Ion Labs ERP system. These specifications will autopopulate onto Form E-701-F1
 
 and should include but not limited to color and size, which are essential for release.
 
 6.12.2 The written specification should be reviewed at time of use and confirmed to be
 
 current. 
 
 6.12.2.1 Ifa written specification is not present or current, one should be created.
 
 6.13 After completion of E-701-F1 Packaging Component Inspection Form, submit the form,
 
 along with the attached COC, to Quality Management or designee for review and
 approval. 
 
 6.14 Quality management/designee will review and approve/reject the results of the
 inspection conducted on the packaging material and sign the form. 
 
 6.14.1 If the inspection fails, Quality Management should place the failing material
 onto QC Hold until a disposition decision has been made. 
 
 6.14.2 Document pass or fail for each inspection on Form E-703-F1 Sampling Log.
 
 
 

[SOP 

 Standard Operating Procedure SOP No | RevNo| Page 
 
 Packaging Component Sampling Procedure E-701 8 S of5 
 
 7.0 Revision History 

| Rev | Date | Description of Changes | CCR # | By |
|-----|----------|------------------------|-------|----|
| 5 | 02/27/13 | Changed SOP number, added in section 5.2.2 reference to SOP C- 708, removed section 5.2.12 | 13-137 | V Iltcheva |
| 3 | 03/05/14 | Complete revision | 14-0202 | V.Iltcheva |
| 4 | 03/24/15 | Revise to include OTC and written specifications per FDA and NSF requirements | 15-0073 | D. Popp |
| 5 | 01/04/19 | Scheduled review: updated procedure and forms to reflect current processes. Changed responsibilities. Revised to be in line with current practice. Revised E-701-F- 6 12719 1 /ra/F3. Obsoleted E-701-F4/F5/F6 wikia Mb alacasones Updated to reflect changes to form E-701-1F. Updated logo and 4a, ; / sisiahtes format. Clarified procedure throughout. Updated responsibilities. hee O28 Je Nicholson g 01/08/25 Updated responsibilities, sample plan, minimum unit sampling CC-25-0009 J. Marpiry requirements | 19-0019 | K. Burris |

 
 

[SOP 

 ISN LABS Form:P|a cka_gE-i7n0g1- CF1o_m po|n ent ICnCspReNctoi:on| - M_eCaCs-2u2r-e0m2e7n0 ts| Revision: 7
 
 Component Inspected 
 Component ID: R#: | 
 
 Component Type: 
 Measurement / Test Topic 
 
 Test Topic Topic Method Units Specification | Tolerance +/- 
 1 Height Measure 
 2 Length Measure 
 3 Width Measure 
 4 Other - 
 5 Other - 
 
 Inspection Summary 
 
 Con S t a a m i p n l e e r # T Re o s p u i l c t s 1 Topic 2 Results| Topic 3 Results| Topic 4 Results| Topic 5 Results
 
 PASS / FAIL 
 
 Signatures Signature Date 
 Completed By 
 
 Approved By 
 (QC)